Response to the Cancer Action Plan 2019 – 2029

We are really pleased after two years to now have a draft cancer plan to review and acknowledge the work that has gone into this draft plan. First up, we should record how disappointing it was, for our cause, and CANGO (Cancer Non-Governmental Organisations) of which Lung Foundation NZ is a member, to not be […]

Our submission to the Health Select Committee

We recently presented to the Health Select Committee. Sincere thanks to the many brave patients and carers for their letters, which highlight the terrible inequity that exists for lung cancer in NZ. Click to view our submission – 2019 July – Lung Foundation NZ – Health Select Committee – Hearing for Lung Cancer Petition Petition […]

See How NZ’s Publicly-Funded Lung Cancer Treatment Options Compare

This report provides a direct comparison of Non-Small Cell Lung Cancer Treatment Options: New Zealand and Australia versus European Society for Medical Oncology (ESMO) Guidelines. Sadly this report demonstrates how far behind Pharmac is with reimbursing standard of care treatments for NZ’s Biggest Cancer Killer and why lung cancer patients die prematurely in New Zealand. […]

Transcript of Guyon Espiner’s interview of Pharmac, CEO, Sarah Fitt

“There are more than a hundred medicines on the PHARMAC waiting list. Some have been there five, ten or even fifteen years. I interviewed the Chief Executive of PHARMAC, Sarah Fitt, and asked her whether she was comfortable with that. Well, if there’s other medicines that have come along and replaced it. If there’s not […]

Lung Cancer in New Zealand – The Facts

Dear Supporter Lung cancer kills more people in New Zealand every year, than breast cancer, prostate cancer and melanoma cancer combined, yet it is the least funded.  Right now, we are witnessing unprecedented suffering and inequity in New Zealand, resulting in premature death for the majority of patients diagnosed with lung cancer. Sadly, almost 1900 […]

Sign our Petition

Please stand with us by signing this petition. Together we can call on the Government to declare lung cancer a health priority and to approve additional budget for Pharmac to fund lung cancer medications, including Keytruda, Alectinib, Osimertinib and Crizotinib, for all Kiwis with advanced lung cancer, irrespective of socio-economic status. https://www.parliament.nz/en/pb/petitions/document/PET_86322/petition-of-philip-hope-for-lung-foundation-new-zealand?fbclid=IwAR0Er6gNod70xvpB1kq3bBVa0LExrfq8GSWo7Gv3KvV-Jr9vwb8mL-NsrDs